Special Interest Group in Cancer
- To identify existing oncology data sources and professional and research networks that may be considered in peri-approval and observational research;
- To identify issues unique to cancer pharmacoepidemiology, and to explore methodological approaches to address these issues; and
- To serve as a resource to the ISPE membership by providing expertise in cancer pharmacoepidemiology and educational content in the area.
- Oncology SIG will be a multi-disciplinary SIG whose goal is to create, facilitate and promote a platform for sharing relevant genomic, pharmacological, clinical, and methodological knowledge.
SIG homepage on ISPE Exchange (login required)